Abiopharma

🔍 Clark Bryan P (Executive)

Company: SunOpta Inc. (STKL)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 14,091 shares of Common Shares (Direct)
  Date: 2026-03-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 65,113.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 6,519 shares of Common Shares at $6.47 per share (Direct)
  Date: 2026-03-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 58,594.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 14,091 shares of Performance Stock Units (Derivative)
  Date: 2026-03-24 | Code: M | Expires: 2026-03-24 | Exercise: 2026-03-24 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Each Performance Stock Unit represents a contingent right to receive one share of STKL common stock.
• F2: This line item reflects the deemed disposition of shares withheld by the Company to satisfy income tax withholding requirements in connection with the vesting of the PSUs.